ABBOTT LABORATORIES (ABT) Costs and Expenses USD 2010 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
Total costs of sales and operating expenses for the period.
Summary
Abbott Laboratories quarterly Costs and Expenses history and growth rate from 2010 to 2024.
  • Abbott Laboratories Costs and Expenses for the quarter ending March 31, 2024 was $8.58B, a 4.13% increase year-over-year.
  • Abbott Laboratories Costs and Expenses for the twelve months ending March 31, 2024 was $34B, a 1.66% decline year-over-year.
Costs and Expenses, Trailing 12 Months (USD)
Costs and Expenses, Quarterly Data (USD)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $34B $8.58B +$340M +4.13% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-02
Q4 2023 $33.6B $8.46B -$326M -3.71% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-16
Q4 2023 $33.6B $33.6B -$1.66B -4.7% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-16
Q3 2023 $34B $8.5B -$144M -1.67% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-01
Q2 2023 $34.1B $8.44B -$445M -5.01% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-03
Q1 2023 $34.5B $8.24B -$745M -8.29% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-02
Q4 2022 $35.3B $8.79B -$303M -3.33% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-16
Q4 2022 $35.3B $35.3B +$641M +1.85% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-16
Q3 2022 $35.6B $8.64B +$258M +3.08% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-01
Q2 2022 $35.3B $8.88B +$50M +0.57% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-03
Q1 2022 $35.3B $8.98B +$636M +7.62% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-04
Q4 2021 $34.7B $9.09B +$821M +9.93% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-16
Q4 2021 $34.7B $34.7B +$5.4B +18.5% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-16
Q3 2021 $33.8B $8.38B +$1.02B +13.9% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-01
Q2 2021 $32.8B $8.83B +$2.18B +32.7% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-02
Q1 2021 $30.6B $8.35B +$1.38B +19.8% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-03
Q4 2020 $29.3B $8.27B +$1.34B +19.4% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-17
Q4 2020 $29.3B $29.3B +$1.88B +6.87% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-17
Q3 2020 $27.9B $7.36B +$480M +6.98% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-03
Q2 2020 $27.4B $6.66B -$117M -1.73% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-04
Q1 2020 $27.5B $6.97B +$172M +2.53% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-05
Q4 2019 $27.4B $6.93B +$325M +4.92% Oct 1, 2019 Dec 31, 2019 10-K 2022-02-18
Q4 2019 $27.4B $27.4B +$444M +1.65% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-18
Q3 2019 $27B $6.88B +$217M +3.26% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-04
Q2 2019 $26.8B $6.77B -$112M -1.63% Apr 1, 2019 Jun 30, 2019 10-Q 2020-07-29
Q1 2019 $26.9B $6.8B +$14M +0.21% Jan 1, 2019 Mar 31, 2019 10-Q 2020-04-29
Q4 2018 $26.9B $6.6B -$338M -4.87% Oct 1, 2018 Dec 31, 2018 10-K 2021-02-19
Q4 2018 $26.9B $26.9B +$1.1B +4.27% Jan 1, 2018 Dec 31, 2018 10-K 2021-02-19
Q3 2018 $27.3B $6.66B +$601M +9.92% Jul 1, 2018 Sep 30, 2018 10-Q 2019-10-31
Q2 2018 $26.7B $6.89B +$634M +10.1% Apr 1, 2018 Jun 30, 2018 10-Q 2019-07-31
Q1 2018 $26B $6.78B +$205M +3.12% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-01
Q4 2017 $25.8B $6.94B +$2.39B +52.7% Oct 1, 2017 Dec 31, 2017 10-K 2020-02-21
Q4 2017 $25.8B $25.8B +$8B +44.9% Jan 1, 2017 Dec 31, 2017 10-K 2020-02-21
Q3 2017 $23.4B $6.06B +$1.66B +37.6% Jul 1, 2017 Sep 30, 2017 10-Q 2018-10-31
Q2 2017 $21.8B $6.25B +$1.73B +38.4% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-01
Q1 2017 $20B $6.58B +$2.22B +50.8% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-02
Q4 2016 $17.8B $4.54B +$171M +3.91% Oct 1, 2016 Dec 31, 2016 10-K 2019-02-22
Q4 2016 $17.8B $17.8B +$289M +1.65% Jan 1, 2016 Dec 31, 2016 10-K 2019-02-22
Q3 2016 $17.7B $4.41B -$32M -0.72% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-02
Q2 2016 $17.7B $4.52B +$76M +1.71% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-02
Q1 2016 $17.6B $4.36B +$74M +1.73% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-03
Q4 2015 $17.5B $4.37B -$154M -3.4% Oct 1, 2015 Dec 31, 2015 10-K 2018-02-16
Q4 2015 $17.5B $17.5B -$110M -0.62% Jan 1, 2015 Dec 31, 2015 10-K 2018-02-16
Q3 2015 $17.7B $4.44B +$86M +1.98% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-03
Q2 2015 $17.6B $4.44B +$61M +1.39% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-03
Q1 2015 $17.5B $4.29B -$103M -2.35% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-04
Q4 2014 $17.6B $4.53B +$937M +26.1% Oct 1, 2014 Dec 31, 2014 10-K 2017-02-17
Q4 2014 $17.6B $17.6B +$124M +0.71% Jan 1, 2014 Dec 31, 2014 10-K 2017-02-17
Q3 2014 $16.7B $4.35B -$1M -0.02% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-05
Q2 2014 $16.7B $4.38B -$439M -9.11% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-04
Q1 2014 $17.2B $4.39B -$373M -7.83% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-06
Q4 2013 $17.5B $3.59B +$378M +11.8% Oct 1, 2013 Dec 31, 2013 10-K 2016-02-19
Q4 2013 $17.5B $17.5B -$166M -0.94% Jan 1, 2013 Dec 31, 2013 10-K 2016-02-19
Q3 2013 $17.1B $4.35B -$603M -12.2% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-06
Q2 2013 $17.7B $4.82B +$69.9M +1.47% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-05
Q1 2013 $17.7B $4.76B -$11.5M -0.24% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-07
Q4 2012 $17.7B $3.21B +$8.24B Oct 1, 2012 Dec 31, 2012 10-K 2015-02-27
Q4 2012 $17.7B $17.7B -$2.09B -10.6% Jan 1, 2012 Dec 31, 2012 10-K 2015-02-27
Q3 2012 $9.45B $4.95B -$4.27B -46.3% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-07
Q2 2012 $13.7B $4.75B -$3.09B -39.4% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-06
Q1 2012 $16.8B $4.77B -$2.97B -38.3% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-08
Q4 2011 $19.8B -$5.03B -$13.2B -162% Oct 1, 2011 Dec 31, 2011 10-K 2014-02-21
Q4 2011 $19.8B $19.8B -$9.3B -32% Jan 1, 2011 Dec 31, 2011 10-K 2014-02-21
Q3 2011 $32.9B $9.22B +$1.73B +23.1% Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-07
Q2 2011 $31.2B $7.84B +$623M +8.63% Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-07
Q1 2011 $30.6B $7.74B +$1.51B +24.3% Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-08
Q4 2010 $29.1B $8.14B Oct 1, 2010 Dec 31, 2010 10-K 2013-02-15
Q4 2010 $29.1B $29.1B Jan 1, 2010 Dec 31, 2010 10-K 2013-02-15
Q3 2010 $7.49B Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-04
Q2 2010 $7.22B Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-04
Q1 2010 $6.23B Jan 1, 2010 Mar 31, 2010 10-Q 2011-05-06
* An asterisk sign (*) next to the value indicates that the value is likely invalid.